Rendezvous endoscopic recanalization for complete esophageal obstruction.

BACKGROUND AND STUDY AIM: Complete esophageal obstruction after (chemo)radiation for head and neck cancers is rare. However, inability to swallow one's own saliva strongly inflicts upon quality of life. Techniques for endoscopic recanalization in complete obstruction are not well established. We assessed the efficacy and safety of rendezvous recanalization. PATIENTS AND METHODS: We performed a retrospective review of all patients who underwent endoscopic recanalization of complete proximal esophageal obstruction after radiotherapy between January 2009 and June 2016. Technical success was defined as an ability to pass an endoscope across the recanalized lumen, clinical success by changes in the dysphagia score. Adverse events were recorded prospectively. RESULTS: 19 patients with complete obstruction (dysphagia IV°), all of whom had failed at least one trial of conventional dilatation, underwent recanalization by endoscopic rendezvous, a combined approach through a gastrostomy and perorally under fluoroscopic control. Conscious sedation was used in all patients. In 18/19 patients (94.7%), recanalization was technically successful. In 14/18 patients (77.8%), the post-intervention dysphagia score changed to ≤ II. Three patients had their PEG removed. Factors negatively associated with success were obstruction length of 50 mm; and tumor recurrence for long-term success. No severe complications were recorded. CONCLUSIONS: Rendezvous recanalization for complete esophageal obstruction is a reliable and safe method to re-establish luminal patency. Differences between technical and clinical success rates highlight the importance of additional functional factors associated with dysphagia. Given the lack of therapeutic alternatives, rendezvous recanalization is a valid option to improve dysphagia.

Computer-aided diagnosis in contrast-enhanced CT colonography: an approach based on contrast.

Automation in colorectal mass detection is achieved as soon as the voxels representing colorectal masses can be automatically segmented. We tested the Hounsfield (HU) value in intensely contrast enhanced high-resolution CT colonography for automated segmentation of colorectal masses in 18 patients with 35 polyps (28 < 10 mm, 7 > or = 10 mm) and 7 carcinomas. Mean HU values of the colonic wall and masses were determined to deduce a gradient threshold for a segmentation process, which encodes the voxels bordering the colonic lumen with a colour ranging in intensity from 0 to 100% according to the selected gradient threshold range in the volume rendering. The results of the automated segmentation process were superimposed on a virtual double contrast and endoscopic display and validated through correlation with morphology. Mean HU values and their standard deviations for the colonic wall, polyps < 10 mm, polyps > or = 10 mm and carcinomas were 63 +/- 24, 154 +/- 38, 116 +/- 41 and 108+/-29 HU, respectively. A gradient threshold ranging from 90 to 160 HU resulted in colour pools in 6 of 7 of polyps > or = 10 mm, and 6 of 7 carcinomas that were significant enough to prospectively guide the reader's attention to these masses. Due to the superposition of "false-positive" voxels in the projection view, the virtual endoscopic perspective was superior to the virtual double contrast display for controlling the segmentation results. The HU value is promising for automated segmentation of colorectal masses but needs to be combined with morphological parameters to render automated colorectal mass detection more accurate. Further refinements of the method with subsequent analysis of its accuracy, as well as analogue studies with contrast-enhanced MRI, appear warranted. More information at http://www.multiorganscreening.org